ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLIN1 | Perilipin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
LIPE | Lipase, hormone-sensitive | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
PLIN4 | Perilipin 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
GPIHBP1 | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ELOVL3 | ELOVL fatty acid elongase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HEPACAM | Hepatic and glial cell adhesion molecule | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL6 | Interleukin 6 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
MT1A | Metallothionein 1A | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | | | | Tissue enhanced |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PLXNA4 | Plexin A4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SNCG | Synuclein, gamma (breast cancer-specific protein 1) | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SOD3 | Superoxide dismutase 3, extracellular | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TNFRSF4 | Tumor necrosis factor receptor superfamily, member 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |